CPT code 0488U: Fetal antigen test, cell-free DNA, selected antigens2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Cell-free DNA testing assesses selected fetal red-cell antigens in alloimmunized pregnancies and reports whether the selected antigen or antigens are detected.
Medicare pays $759.05 for 0488U under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$759.05
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2025
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 7 sections
What 0488U covers
This assay analyzes cell-free DNA from a pregnant patient to assess whether the fetus has selected red-cell antigens: Rh C, c, D, or E; Duffy Fya; or Kell K. Results report the selected antigen or antigens as detected or not detected. Obstetricians and maternal-fetal medicine specialists may order the test in an alloimmunized pregnancy when fetal antigen status is relevant to care.
Report 0488U for this assay. Medicare pays it only through the Clinical Laboratory Fee Schedule (CLFS). The 2026 national CLFS amount is $759.05, unchanged from 2025; the same amount applies across states and localities, with no geographic or office-versus-facility adjustment. There is no separate physician fee schedule payment for interpretation.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 0488U
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 0488U. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Not on the physician fee schedule
The physician fee schedule doesn’t list 0488U: Medicare pays the test only from the CLFS.
0488U on the lab fee schedule since 2024
0488U · CLFS 2026 Q4 (current)
$759.05
Unchanged since Jan 1, 2025
Every change on file
- Jan 1, 2025 · CLFS 2025 Q1MAC-priced → $759.05
9 quarterly CLFS releases on file, first CLFS 2024 Q4. A code missing from a quarter wasn’t on that release.
0488U compared with similar tests
- 86850Antibody screenRed blood cell antibodies$9.77
- 86850 screens the maternal sample for red-cell antibodies. 0488U uses cell-free DNA to assess selected fetal antigens.
- 0489UPrenatal cfDNA testSingle-gene fetal risk score$1,153.62
- 0489U is an obstetric single-gene cell-free DNA sequencing assay. 0488U assesses selected fetal red-cell antigens in alloimmunized pregnancies.
- 86901Rh typingD antigen$2.99
- 86901 determines the patient’s Rh type. 0488U assesses selected fetal antigens using cell-free DNA.
0488U billing questions
When is 0488U appropriate?
Use it for cell-free DNA testing of selected fetal red-cell antigens in an alloimmunized pregnancy. It reports fetal antigen status, not the maternal antibody screen.
Which antigens can this assay assess?
The assay may assess Rh C, c, D, or E; Duffy Fya; or Kell K. Results report the selected antigen or antigens as detected or not detected.
Is 0488U the same as a maternal antibody screen?
No. Code 0488U assesses selected fetal antigens using cell-free DNA; 86850 is a maternal red-cell antibody screen.
How does Medicare pay for 0488U?
Medicare pays 0488U from the CLFS at one national amount across localities. There is no separate physician fee schedule payment for interpretation.
How does 0488U differ from 0489U?
0488U assesses selected fetal red-cell antigens in an alloimmunized pregnancy. 0489U is an obstetric single-gene cell-free DNA sequencing assay.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 0488U and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist